ROBERTS BRANDI (Chief Financial Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/22/2026ACC: 0001193125-26-276880
Officer· Chief Financial Officer
Since Feb 2026
+62.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
62.50K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+62.50K
Price / share
—
Trade value
—
% of position
41.7%
6/22/2026
150K→212.50K
Total
Net shares
+62.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/22/2026 | A · Award | +62.50K | — | — | 41.7% | 150K | 212.50K |
| Total | +62.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported